Regional Advantages

Renowned for its location, business climate and affordable cost of living, Northeast Indiana is consistently ranked best in the Midwest.

Industry Information

With access to 40,000 graduating students annually, join the impressive list of major employers leading Northeast Indiana’s top industries.

Business Leadership

Increasing personal income, growing the population and raising educational attainment. Join us!

About Living Here

Northeast Indiana is family-friendly, affordable and offers diverse opportunities to make it your own in Northeast Indiana.

Jobs & Internships

Join Northeast Indiana, a growing, vibrant community. From your next career to your next promotion, make it your own in Northeast Indiana.

Zimmer Biomet lands FDA clearance

January 5th, 2018

By Alex Brown | Inside INdiana Business

Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has cleared a key hurdle for a shoulder replacement system. The U.S. Food and Drug Administration has given clearance for the medical device company's Sidus Stem-Free Shoulder system.

Zimmer Biomet says Sidus is designed to benefit eligible shoulder surgery patients with a less invasive surgery, bone preservation and a more personalized fit, according to the company's website.

"The FDA clearance of the Sidus Stem-Free Shoulder system comes at a time when Zimmer Biomet is accelerating the pace of innovation," said Bryan Hanson, chief executive officer of Zimmer Biomet. "We launched Sidus in Europe in 2012 and initiated a clinical study in the U.S. in 2015. During that time, the product has demonstrated strong clinical performance."

Now that it has received FDA clearance, Zimmer Biomet says the system will be available in the United States in the first quarter of 2018.

Categories Other Business News